ESR1 and neoplasm: Lastly, it is also important to consider the fact that certain ER antagonists such as tamoxifen, fulvestrant, and raloxifene act as GPER agonists [6], with evidence that tamoxifen can upregulate aromatase activity in tumor and stromal fibroblasts [134].